Stock Analysis
Fujian Wanchen Biotechnology Group Second Quarter 2024 Earnings: CN¥0.032 loss per share (vs CN¥0.38 loss in 2Q 2023)
Fujian Wanchen Biotechnology Group (SZSE:300972) Second Quarter 2024 Results
Key Financial Results
- Revenue: CN¥6.08b (up 318% from 2Q 2023).
- Net loss: CN¥5.30m (loss narrowed by 91% from 2Q 2023).
- CN¥0.032 loss per share (improved from CN¥0.38 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Fujian Wanchen Biotechnology Group Earnings Insights
Looking ahead, revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Food industry in China.
Performance of the Chinese Food industry.
The company's shares are up 27% from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with Fujian Wanchen Biotechnology Group.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:300972
Fujian Wanchen Biotechnology Group
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China.